Induction ChemotherapyAntineoplastic Combined Chemotherapy ProtocolsCarcinomaCarcinoma, Squamous CellCombined Modality TherapyCisplatinTreatment OutcomeNeoplasm StagingPaclitaxelRemission InductionCarboplatinUrologic NeoplasmsSurvival RateChemotherapy, AdjuvantSurvival AnalysisFluorouracilPrognosisUterine Cervical NeoplasmsAdenocarcinomaDisease-Free SurvivalHead and Neck NeoplasmsCarcinoma, HepatocellularAntineoplastic AgentsNeoadjuvant TherapyLung NeoplasmsCyclophosphamideEtoposideCytarabineDoxorubicinStomach NeoplasmsLeukemia, Myeloid, AcuteTaxoidsDaunorubicinDrug Administration ScheduleBreast NeoplasmsCarcinoma, Non-Small-Cell LungIfosfamideNasopharyngeal NeoplasmsRadiotherapy, AdjuvantNeoplasm Recurrence, LocalVincristineEnzyme InductionCarcinoma in SituChemoradiotherapyHypopharyngeal NeoplasmsLiver NeoplasmsLaryngectomyMethotrexatePrecursor Cell Lymphoblastic Leukemia-LymphomaVinblastineRadiotherapyRadiotherapy DosageFollow-Up StudiesIdarubicinLaryngeal NeoplasmsBleomycinTime FactorsDeoxycytidineKaplan-Meier EstimateCarcinoma, PapillaryLeukemia, MyeloidNeoplasm MetastasisImmunohistochemistryTumor Markers, BiologicalTransplantation, AutologousSalvage TherapyCarcinoma, Small CellLymphatic MetastasisCarcinoma, Ductal, BreastAntimetabolites, AntineoplasticCell Line, TumorNeutropeniaProspective StudiesTesticular NeoplasmsMelphalanGranulocyte Colony-Stimulating FactorDose-Response Relationship, DrugDrug Resistance, NeoplasmCarcinoma, Basal CellRetrospective StudiesEsophageal NeoplasmsOropharyngeal NeoplasmsMucositisAsparaginaseDose FractionationOrgan Sparing TreatmentsMitoxantroneRadiotherapy, High-EnergyTumor Cells, CulturedOrganoplatinum CompoundsCarcinoma, Transitional CellDisease ProgressionVindesineOvarian NeoplasmsCranial IrradiationGlossectomyLevoleucovorinMouth NeoplasmsHematopoietic Stem Cell TransplantationNeoplasms, Germ Cell and Embryonal